Medcura Raises $7.4M in Funding
- Medcura, Inc., a Riverdale, Md.-based commercial-stage medical device company, raised $7.4m in funding
- The financing includes the sale of Series A Preferred stock as well as common stock based, in part, from certain investors benefitting from a Maryland Investment Incentive Program
- The company intends to use the funds to expand its product line and develop its lead surgical candidate for clinical evaluation
- The company is a commercial-stage medical device company developing versatile hemostatic products for surgical, medical, and consumer applications
- It is involved in the development and commercialization of a broad range of hemostatic and wound treatment products
- These products all benefit from the company’s intellectual property estate, emergent FDA regulatory experience and continual expansion of its manufacturing capabilities
